Related Experiment Video

Updated: Jul 10, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:39

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

120

Interaction and Collaboration of SP1, HIF-1, and MYC in Regulating the Expression of Cancer-Related Genes to Further

Kotohiko Kimura1, Tiffany L B Jackson1, Ru Chih C Huang1

  • 1Department of Biology, Johns Hopkins University, 3400 N. Charles Street, Baltimore, MD 21218-2685, USA.

Current Issues in Molecular Biology
|November 24, 2023
PubMed

Insights

Specificity protein 1 (SP1), hypoxia-inducible factor 1 (HIF-1), and MYC are key cancer regulators. Understanding their interactions is crucial for developing novel anticancer therapies targeting these transcription factors.

Area of Science:

  • * Molecular biology
  • * Cancer research
  • * Transcription factor regulation

Background:

  • * Specificity protein 1 (SP1), hypoxia-inducible factor 1 (HIF-1), and MYC are critical transcription factors (TFs) involved in cancer development.
  • * These TFs are frequently overexpressed in tumors, highlighting their significance in oncogenesis.
  • * SP1, HIF-1, and MYC regulate each other and collaborate to control genes vital for cancer progression.

Purpose of the Study:

  • * To review the interactions and collaborative roles of SP1, HIF1A, and MYC in regulating cancer-related genes.
  • * To explore the potential of these TFs as targets for anticancer drug development.
  • * To discuss the challenges and opportunities in targeting MYC, SP1, and HIF-1 therapeutically.

Main Methods:

  • * Literature review and systems analysis of regulatory networks in cancer.
  • * Examination of the interplay between SP1, HIF-1, and MYC.
  • * Analysis of gene expression modulation by these transcription factors.

Main Results:

  • * SP1, HIF-1, and MYC function as master regulators in cancer, crucial for tumor development.
  • * These TFs mutually regulate each other's expression and cooperate in controlling numerous cancer-associated genes.
  • * While SP1 and HIF-1 have existing inhibitors, developing effective MYC inhibitors remains a significant challenge.

Conclusions:

  • * The intricate network of SP1, HIF-1, and MYC interactions presents a promising avenue for novel anticancer strategies.
  • * Targeting the collaborative functions of these TFs could offer a potent approach to inhibit cancer development.
  • * Further research into MYC inhibition, alongside SP1 and HIF-1, is essential for advancing cancer therapy.
Keywords:
MYCSP1cancerhypoxia-inducible factor 1

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.3K
Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

6.9K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K